Phase Ib trial of ubidecarenone (BPM 31510) in patients with solid tumours stratified by phenotype

Trial Profile

Phase Ib trial of ubidecarenone (BPM 31510) in patients with solid tumours stratified by phenotype

Planning
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs Ubidecarenone (Primary)
  • Indications Brain cancer; Breast cancer; Liver cancer; Pancreatic cancer; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2013 New trial record
    • 21 Nov 2013 300-400 patients are expected to be enrolled, according to a Berg media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top